A Study of the Concurrent Use of AGN-190584 and AGN-199201 in Participants With Presbyopia
Status:
Completed
Trial end date:
2017-10-18
Target enrollment:
Participant gender:
Summary
This study will identify the optimum concentrations of AGN-199201 and AGN-190584 when dosed
in combination once a day for the improvement of uncorrected near visual acuity in
participants with presbyopia (inability to focus on items close-up).